Activity Preview

Live

Enhancing Clinical Treatment Through Use of Prescription Drug Monitoring Programs (Archived Webinar)

Activity Type:

  • On Demand


Release Date: 12/8/2015

Expiration Date: 12/31/2020

  • AMA PRA Category 1: 1
  • Participation: 1

Register

Overview

Prescription drugs, when used under the direction and supervision of practitioners, bring relief and provide treatment to millions of patients. These same drugs have been the source of the most serious public health crisis in recent times. Today, prescription drug abuse is a national epidemic affecting individuals, families, and communities. To combat this major public health crisis, states have passed Prescription Drug Monitoring Program (PDMP) legislation. A PDMP is an effective tool for improving patient safety and curtailing the abuse and diversion of prescription drugs by monitoring the prescribing and dispensing of controlled substances. By accessing this information before they prescribe or dispense, a practitioner can provide better patient care and help protect their practice. When PDMP reports are utilized by practitioners it reduces the quantity of drugs diverted to illicit markets and increases the quality of care rendered to patients. This webinar will detail PDMPs and show how they can be most effective. 

Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. pcssnow.org

Pricing

  • General Member - Free
  • Resident-Fellow Member - Free
  • Medical Student Member - Free
  • Non-Member - Free

Educational Objectives

  • State the purpose of prescription drug monitoring programs (PDMPs).
  • Explain how PDMP information can be a beneficial tool in a physician’s practice.
  • Summarize the capabilities of each state’s PDMP.
  • Cite how to connect to the PDMP.

Target Audience

Physicians who have a waiver to treat opioid dependence in an office-based setting and other interested clinicians

Estimated Time to Complete

Estimated Duration: 1 hour
Program Begin Date: December 8, 2015
Program Review Date: November 1, 2018
Program End Date: December 31, 2020

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 60% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the date of completion and hours earned. 

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Faculty

  • Patrick Knue, Program Coordinator, PDMP Training and Technical Assistance Center (TTAC).Reports no financial relationships with commercial interests.

Program Planners

  • Andrew Saxon, M.D., Professor, Department of Psychiatry & Behavioral Sciences; Director, Addiction Psychiatry Residency Program, University of Washington; Director, Center of Excellence in Substance Abuse Treatment and Education (CESATE) VA Puget Sound Health Care System. Reports no financial relationships with commercial interests.
  • Beatrice Eld, Associate Director, Addiction Psychiatry, American Psychiatric Association. Reports no financial relationships with commercial interests
  • John A. Renner, Jr., M.D., Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.
  • Frances R. Levin, M.D., Kennedy Leavy Professor of Psychiatry at Columbia University Medical Center; Director, Addiction Psychiatry Fellowship, New York Presbyterian Hospital; Director of Clinical and Educational Activities for the Division on Substance Abuse, New York State Psychiatric Institute. Disclosure: Consultant: Major League Baseball, Grant/Research Support: US World Med.

Program Reviewer

  • John A. Renner, Jr., M.D., Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stock/other financial options: Johnson & Johnson and General Electric.

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh: Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact educme@psych.orgfor questions about this course | Contact learningcenter@psych.org for technical assistance

Register